Should cytoreductive treatment be performed before transplantation in patients with high-risk myelodysplastic syndrome?

J Clin Oncol. 2013 Jul 20;31(21):2761-2. doi: 10.1200/JCO.2012.48.0525. Epub 2013 Jun 17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Azacitidine / therapeutic use*
  • Female
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Male
  • Myelodysplastic Syndromes / drug therapy*
  • Myelodysplastic Syndromes / surgery*

Substances

  • Antimetabolites, Antineoplastic
  • Azacitidine